The HKAPI Annual Dinner 2023 on June 7th, held under the theme of Innovate, Integrate & Impact, was the first annual dinner event since 2019 due to the COVID-19 pandemic
We are excited to share that the HKAPI has welcomed four new members to our organization over the past year. These companies are bringing new and diverse expertise to our organization and we are thrilled to have them on board.
HKAPI has announced the election of two new members to its Board of Directors. Mr Neo Lam, from Baxter, and Mr Jonathan Chin, from Boehringer Ingelheim, have been elected to join the Board and will serve until the end of this term (2024).
The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.